optimalisering av brystkreftbehandling
- Prosjektnummer
- 46011600-23
- Ansvarlig person
- Ingrid S. Gribbestad
- Institusjon
- NTNU, ISB
- Prosjektkategori
- Flerårig prosjekt 2007
- Helsekategori
- Oncogenesis & Cancer Research
- Forskningsaktivitet
- Medisinsk teknologi
Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues.
Magn Reson Med 2008 Sep;60(3):510-6.
PMID: 18727052
Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy.
Mol Cancer 2008;7():33. Epub 2008 apr 25
PMID: 18439252
Characterization of brain metastases using high-resolution magic angle spinning MRS.
NMR Biomed 2008 Feb;21(2):175-85.
PMID: 17542042
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.
PLoS ONE 2008;3(8):e3062. Epub 2008 aug 26
PMID: 18725978
Outcome of whole-brain irradiation for breast cancer patients.
Acta Oncol 2008;47(2):261-6.
PMID: 17882559
Adjuvant cyclic Tamoxifen and Megestrol acetate treatment in postmenopausal breast cancer patients--longterm follow-up.
Eur J Surg Oncol 2008 Jan;34(1):6-12. Epub 2007 sep 18
PMID: 17881183
High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer
Progress in Nuclear Magnetic Resonance Spectroscopy , in press
Advanced MR imaging, MR metabolomics and genetic mapping of breast cancer Clinical tools for personalized patient treatment.
invited lecture Johns Hopkins Medical University, Baltimore USA
Advanced MR imaging, MR metabolomics and genetic mapping of breast cancer Clinical tools for personalized patient treatment.
Invited lecture, Radboud University Nijmegen, Nederland
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU